MD Anderson Cancer Center at Cooper- Two Cooper Plaza — Camden, New Jersey

MD Anderson Cancer Center at Cooper- Two Cooper Plaza is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center at Cooper- Two Cooper Plaza has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: Genmab.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Camden

Browse all research sites in New Jersey · View every site in Camden

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center at Cooper- Two Cooper Plaza?

MD Anderson Cancer Center at Cooper- Two Cooper Plaza has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center at Cooper- Two Cooper Plaza conducted?

MD Anderson Cancer Center at Cooper- Two Cooper Plaza has 1 clinical trials on record, with 1 currently active. Their work covers High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Is MD Anderson Cancer Center at Cooper- Two Cooper Plaza accredited by Crixeo Clinical Trials?

MD Anderson Cancer Center at Cooper- Two Cooper Plaza has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center at Cooper- Two Cooper Plaza?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.